352 related articles for article (PubMed ID: 32528400)
1. Exploring Sphingolipid Implications in Neurodegeneration.
Alessenko AV; Albi E
Front Neurol; 2020; 11():437. PubMed ID: 32528400
[TBL] [Abstract][Full Text] [Related]
2. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
3. Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy.
Tringali C; Giussani P
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887154
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Bouscary A; Quessada C; René F; Spedding M; Turner BJ; Henriques A; Ngo ST; Loeffler JP
Semin Cell Dev Biol; 2021 Apr; 112():82-91. PubMed ID: 33160824
[TBL] [Abstract][Full Text] [Related]
5. Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Jan; 56(1):174-185. PubMed ID: 29687345
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids in Alzheimer's disease, how can we target them?
Crivelli SM; Giovagnoni C; Visseren L; Scheithauer AL; de Wit N; den Hoedt S; Losen M; Mulder MT; Walter J; de Vries HE; Bieberich E; Martinez-Martinez P
Adv Drug Deliv Rev; 2020; 159():214-231. PubMed ID: 31911096
[TBL] [Abstract][Full Text] [Related]
7. [The role of sphingolipids in pathogenesis of amyotrophic lateral sclerosis].
Alessenko AV; Gutner UA; Nebogatikov VO; Shupik MA; Ustyugov AA
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):131-140. PubMed ID: 34481449
[TBL] [Abstract][Full Text] [Related]
8. Sphingolipid metabolism in brain insulin resistance and neurological diseases.
Mei M; Liu M; Mei Y; Zhao J; Li Y
Front Endocrinol (Lausanne); 2023; 14():1243132. PubMed ID: 37867511
[TBL] [Abstract][Full Text] [Related]
9. The Link between Gaucher Disease and Parkinson's Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism.
Indellicato R; Trinchera M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284408
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis.
Quinville BM; Deschenes NM; Ryckman AE; Walia JS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071409
[TBL] [Abstract][Full Text] [Related]
12. The roles of ceramide and complex sphingolipids in neuronal cell function.
Buccoliero R; Futerman AH
Pharmacol Res; 2003 May; 47(5):409-19. PubMed ID: 12676515
[TBL] [Abstract][Full Text] [Related]
13. Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders.
Piccinini M; Scandroglio F; Prioni S; Buccinnà B; Loberto N; Aureli M; Chigorno V; Lupino E; DeMarco G; Lomartire A; Rinaudo MT; Sonnino S; Prinetti A
Mol Neurobiol; 2010 Jun; 41(2-3):314-40. PubMed ID: 20127207
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
15. Ceramide and Sphingosine-1-Phosphate in Cell Death Pathways : Relevance to the Pathogenesis of Alzheimer's Disease.
Chakrabarti SS; Bir A; Poddar J; Sinha M; Ganguly A; Chakrabarti S
Curr Alzheimer Res; 2016; 13(11):1232-1248. PubMed ID: 27335046
[TBL] [Abstract][Full Text] [Related]
16. Role of sphingolipid-mediated cell death in neurodegenerative diseases.
Ariga T; Jarvis WD; Yu RK
J Lipid Res; 1998 Jan; 39(1):1-16. PubMed ID: 9469581
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy.
Lee JY; Jin HK; Bae JS
BMB Rep; 2020 Jan; 53(1):28-34. PubMed ID: 31818364
[TBL] [Abstract][Full Text] [Related]
18. Role of sphingolipid metabolism in neurodegeneration.
Alaamery M; Albesher N; Aljawini N; Alsuwailm M; Massadeh S; Wheeler MA; Chao CC; Quintana FJ
J Neurochem; 2021 Jul; 158(1):25-35. PubMed ID: 32402091
[TBL] [Abstract][Full Text] [Related]
19. Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases.
Pujol-Lereis LM
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330872
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine kinase 1/sphingosine-1-phosphate receptors dependent signalling in neurodegenerative diseases. The promising target for neuroprotection in Parkinson's disease.
Motyl J; Strosznajder JB
Pharmacol Rep; 2018 Oct; 70(5):1010-1014. PubMed ID: 30138818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
